James Davis is Chairman, Chief Executive Officer and President of Quest Diagnostics Inc (DGX). The company reported total compensation of $15,498,479 for fiscal year 2025.
| Salary | $1,250,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $8,762,861 |
| Option awards | $2,999,873 |
| Non-equity incentive plan | $2,205,844 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $279,901 |
| Total | $15,498,479 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Quest Diagnostics Inc filed April 6, 2026, accession 0001140361-26-013356.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman, Chief Executive Officer and President | $1,250,000 | $0 | $8,762,861 | $2,999,873 | $2,205,844 | $0 | $279,901 | $15,498,479 |
| FY2024 | Chairman, Chief Executive Officer and President | $1,250,000 | — | $8,239,724 | $2,843,630 | $1,811,250 | — | $260,258 | $14,404,862 |
| FY2023 | Chairman, Chief Executive Officer and President | $1,175,000 | — | $7,290,745 | $2,499,848 | $1,361,531 | — | $346,710 | $12,673,834 |
| FY2022 | Chairman, Chief Executive Officer and President | $805,769 | $0 | $8,542,446 | $1,249,946 | $1,082,853 | $0 | $202,012 | $11,883,027 |
Totals as disclosed in each year's own compensation disclosure for Quest Diagnostics Inc.
| Peer-group chief executive median | $17,129,140 |
|---|---|
| Difference from that median | $-1,630,661 |
| Percentile within the disclosed peer group | 31st |
| Peers with a disclosed figure | 13 |
Medians and percentiles are computed across the peer group Quest Diagnostics Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| James Davis this page | Chairman, Chief Executive Officer and President | $15,498,479 |
| Sam Samad | Executive Vice President and Chief Financial Officer | $4,427,141 |
| Catherine Doherty | Executive Vice President, Regional Businesses | $3,562,946 |
| Karthik Kuppusamy | Senior Vice President, Clinical Solutions | $2,579,823 |
| Michael Prevoznik | Senior Vice President and General Counsel | $2,563,593 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Quest Diagnostics Inc compensation brief.
James Davis's compensation sits inside Quest Diagnostics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.